Although inhibition of NKX2-5 in healthy vessels could potentially block vital repair pathways, when NKX2-5 reactivation has already become pathological, such as in pulmonary hypertension and atherosclerosis or following angioplasty and stenting, it may be very beneficial. Here, NKX2-5 is linked to atherosclerosis.